In both healthy individuals and patients with T2DM [196,197], rectal administration of primary bile acid, taurocholic acid (TCA), has also been shown to stimulate GLP-1 and PYY secretion in a dose-dependent manner, although the PYY response seems to be more robust than that of GLP-1. The gene discussed is PYY; the disease is type 2 diabetes mellitus.